- Home
- SHC vs APLS Comparison
SHC vs APLS Comparison
Compare SHC & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHC
- APLS
- Stock Information
- Founded
- SHC 2015
- APLS 2009
- Country
- SHC United States
- APLS United States
- Employees
- SHC N/A
- APLS N/A
- Industry
- SHC Medical Specialities
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- SHC Health Care
- APLS Health Care
- Exchange
- SHC Nasdaq
- APLS Nasdaq
- Market Cap
- SHC N/A
- APLS 3.3B
- IPO Year
- SHC 2020
- APLS 2017
- Fundamental
- Price
- SHC $11.55
- APLS $22.02
- Analyst Decision
- SHC Strong Buy
- APLS Buy
- Analyst Count
- SHC 5
- APLS 18
- Target Price
- SHC $16.30
- APLS $45.53
- AVG Volume (30 Days)
- SHC 1.3M
- APLS 1.8M
- Earning Date
- SHC 05-01-2025
- APLS 05-06-2025
- Dividend Yield
- SHC N/A
- APLS N/A
- EPS Growth
- SHC N/A
- APLS N/A
- EPS
- SHC 0.16
- APLS N/A
- Revenue
- SHC $1,100,441,000.00
- APLS $781,367,000.00
- Revenue This Year
- SHC $4.14
- APLS $12.95
- Revenue Next Year
- SHC $6.11
- APLS $21.35
- P/E Ratio
- SHC $75.07
- APLS N/A
- Revenue Growth
- SHC 4.88
- APLS 97.02
- 52 Week Low
- SHC $10.71
- APLS $23.25
- 52 Week High
- SHC $17.08
- APLS $59.91
- Technical
- Relative Strength Index (RSI)
- SHC 42.46
- APLS 33.73
- Support Level
- SHC $11.62
- APLS $23.25
- Resistance Level
- SHC $12.95
- APLS $24.88
- Average True Range (ATR)
- SHC 0.43
- APLS 0.90
- MACD
- SHC 0.06
- APLS 0.06
- Stochastic Oscillator
- SHC 37.73
- APLS 0.55
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.